Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Some adverse effects were observed in repeated dose toxicity studies at a high dose/concentration.

Key value for chemical safety assessment

Repeated dose toxicity: inhalation - systemic effects

Link to relevant study records
Reference
Endpoint:
sub-chronic toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
other information
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
data from handbook or collection of data
Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Route of administration:
inhalation: aerosol
Type of inhalation exposure:
not specified
Vehicle:
not specified
Analytical verification of doses or concentrations:
not specified
Duration of treatment / exposure:
13 weeks + 1 month recovery
Frequency of treatment:
5 days/week - 6 hours/day
Dose / conc.:
400 mg/m³ air
No. of animals per sex per dose:
26 animal per sex + 10 animals per group observed for recovery.
Control animals:
yes
Dose descriptor:
NOAEC
Effect level:
< 400 mg/m³ air

At 400 mg/m3: body weight ↓, nose: degeneration/atrophy (not reversible) in the dorsomedial aspect of the dorsal endoturbinates and focal respiratory metaplasia of the olfactory mucosa of the dorsal meatus and degeneration/atrophy

Conclusions:
Under the test conditions, several adverse effects were observed in rats after repeated inhalation exposure to the substance at 400 mg/m3.

Repeated dose toxicity: inhalation - local effects

Link to relevant study records
Reference
Endpoint:
sub-chronic toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
other information
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
data from handbook or collection of data
Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Route of administration:
inhalation: aerosol
Type of inhalation exposure:
not specified
Vehicle:
not specified
Analytical verification of doses or concentrations:
not specified
Duration of treatment / exposure:
13 weeks + 1 month recovery
Frequency of treatment:
5 days/week - 6 hours/day
Dose / conc.:
400 mg/m³ air
No. of animals per sex per dose:
26 animal per sex + 10 animals per group observed for recovery.
Control animals:
yes
Dose descriptor:
NOAEC
Effect level:
< 400 mg/m³ air

At 400 mg/m3: body weight ↓, nose: degeneration/atrophy (not reversible) in the dorsomedial aspect of the dorsal endoturbinates and focal respiratory metaplasia of the olfactory mucosa of the dorsal meatus and degeneration/atrophy

Conclusions:
Under the test conditions, several adverse effects were observed in rats after repeated inhalation exposure to the substance at 400 mg/m3.

Additional information

Justification for classification or non-classification

Data available are deemed to be inconclusive to assess the classification in accordance with CLP Regulation.